Submitted by Anonymous (not verified) on 24 November 2023 - 10:27
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Achondroplasia, Date of authorisation: 26/08/2021, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Achondroplasia, Date of authorisation: 26/08/2021, Revision: 4, Status: Authorised